nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextroamphetamine—Blood pressure systolic increased—Sorafenib—liver cancer	0.117	0.191	CcSEcCtD
Dextroamphetamine—L-Phenylalanine—TAT—liver cancer	0.022	0.367	CrCbGaD
Dextroamphetamine—Blood pressure increased—Sorafenib—liver cancer	0.017	0.0278	CcSEcCtD
Dextroamphetamine—Cardiomyopathy—Epirubicin—liver cancer	0.0123	0.0201	CcSEcCtD
Dextroamphetamine—Pseudoephedrine—IL2—liver cancer	0.0122	0.203	CrCbGaD
Dextroamphetamine—Mood swings—Sorafenib—liver cancer	0.0117	0.0191	CcSEcCtD
Dextroamphetamine—Cardiomyopathy—Doxorubicin—liver cancer	0.0114	0.0186	CcSEcCtD
Dextroamphetamine—Abdominal pain upper—Sorafenib—liver cancer	0.0113	0.0184	CcSEcCtD
Dextroamphetamine—Toxic epidermal necrolysis—Sorafenib—liver cancer	0.0111	0.0181	CcSEcCtD
Dextroamphetamine—Erectile dysfunction—Sorafenib—liver cancer	0.00984	0.016	CcSEcCtD
Dextroamphetamine—Weight decreased—Sorafenib—liver cancer	0.00966	0.0158	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.00944	0.0154	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Sorafenib—liver cancer	0.00939	0.0153	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Sorafenib—liver cancer	0.00934	0.0152	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Sorafenib—liver cancer	0.00808	0.0132	CcSEcCtD
Dextroamphetamine—Viral infection—Epirubicin—liver cancer	0.00697	0.0114	CcSEcCtD
Dextroamphetamine—Angioedema—Sorafenib—liver cancer	0.0068	0.0111	CcSEcCtD
Dextroamphetamine—Dyskinesia—Epirubicin—liver cancer	0.0067	0.0109	CcSEcCtD
Dextroamphetamine—Viral infection—Doxorubicin—liver cancer	0.00645	0.0105	CcSEcCtD
Dextroamphetamine—Hypertension—Sorafenib—liver cancer	0.00643	0.0105	CcSEcCtD
Dextroamphetamine—Dry mouth—Sorafenib—liver cancer	0.0062	0.0101	CcSEcCtD
Dextroamphetamine—Dyskinesia—Doxorubicin—liver cancer	0.0062	0.0101	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Sorafenib—liver cancer	0.00607	0.00991	CcSEcCtD
Dextroamphetamine—Infection—Sorafenib—liver cancer	0.00604	0.00984	CcSEcCtD
Dextroamphetamine—Anorexia—Sorafenib—liver cancer	0.00579	0.00944	CcSEcCtD
Dextroamphetamine—Dyspnoea—Sorafenib—liver cancer	0.00542	0.00883	CcSEcCtD
Dextroamphetamine—Dyspepsia—Sorafenib—liver cancer	0.00535	0.00872	CcSEcCtD
Dextroamphetamine—Decreased appetite—Sorafenib—liver cancer	0.00528	0.00861	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Sorafenib—liver cancer	0.00524	0.00855	CcSEcCtD
Dextroamphetamine—Fatigue—Sorafenib—liver cancer	0.00524	0.00854	CcSEcCtD
Dextroamphetamine—Constipation—Sorafenib—liver cancer	0.00519	0.00847	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Sorafenib—liver cancer	0.00497	0.0081	CcSEcCtD
Dextroamphetamine—Urticaria—Sorafenib—liver cancer	0.00483	0.00787	CcSEcCtD
Dextroamphetamine—Body temperature increased—Sorafenib—liver cancer	0.0048	0.00783	CcSEcCtD
Dextroamphetamine—Abdominal pain—Sorafenib—liver cancer	0.0048	0.00783	CcSEcCtD
Dextroamphetamine—Cerebrovascular accident—Epirubicin—liver cancer	0.00466	0.0076	CcSEcCtD
Dextroamphetamine—Affect lability—Epirubicin—liver cancer	0.0045	0.00733	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Sorafenib—liver cancer	0.00448	0.0073	CcSEcCtD
Dextroamphetamine—Asthenia—Sorafenib—liver cancer	0.00436	0.00711	CcSEcCtD
Dextroamphetamine—Mood swings—Epirubicin—liver cancer	0.00433	0.00706	CcSEcCtD
Dextroamphetamine—Cerebrovascular accident—Doxorubicin—liver cancer	0.00431	0.00703	CcSEcCtD
Dextroamphetamine—Abdominal pain upper—Epirubicin—liver cancer	0.00417	0.0068	CcSEcCtD
Dextroamphetamine—Affect lability—Doxorubicin—liver cancer	0.00416	0.00678	CcSEcCtD
Dextroamphetamine—Diarrhoea—Sorafenib—liver cancer	0.00416	0.00678	CcSEcCtD
Dextroamphetamine—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00411	0.00671	CcSEcCtD
Dextroamphetamine—Pseudoephedrine—TNF—liver cancer	0.0041	0.0684	CrCbGaD
Dextroamphetamine—Nateglinide—PPARG—liver cancer	0.00403	0.0671	CrCbGaD
Dextroamphetamine—Dizziness—Sorafenib—liver cancer	0.00402	0.00655	CcSEcCtD
Dextroamphetamine—Mood swings—Doxorubicin—liver cancer	0.004	0.00653	CcSEcCtD
Dextroamphetamine—Tranylcypromine—CYP2E1—liver cancer	0.00398	0.0663	CrCbGaD
Dextroamphetamine—Vomiting—Sorafenib—liver cancer	0.00386	0.0063	CcSEcCtD
Dextroamphetamine—Abdominal pain upper—Doxorubicin—liver cancer	0.00386	0.00629	CcSEcCtD
Dextroamphetamine—Rash—Sorafenib—liver cancer	0.00383	0.00625	CcSEcCtD
Dextroamphetamine—Dermatitis—Sorafenib—liver cancer	0.00383	0.00624	CcSEcCtD
Dextroamphetamine—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00381	0.00621	CcSEcCtD
Dextroamphetamine—Headache—Sorafenib—liver cancer	0.00381	0.00621	CcSEcCtD
Dextroamphetamine—Nausea—Sorafenib—liver cancer	0.00361	0.00588	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Epirubicin—liver cancer	0.0036	0.00588	CcSEcCtD
Dextroamphetamine—Weight decreased—Epirubicin—liver cancer	0.00357	0.00582	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00349	0.00569	CcSEcCtD
Dextroamphetamine—Urinary tract infection—Epirubicin—liver cancer	0.00342	0.00558	CcSEcCtD
Dextroamphetamine—Sweating—Epirubicin—liver cancer	0.00337	0.0055	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Doxorubicin—liver cancer	0.00333	0.00544	CcSEcCtD
Dextroamphetamine—Weight decreased—Doxorubicin—liver cancer	0.0033	0.00539	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00323	0.00527	CcSEcCtD
Dextroamphetamine—Benzyl alcohol—CYP2E1—liver cancer	0.00322	0.0536	CrCbGaD
Dextroamphetamine—Benzyl alcohol—CYP1A1—liver cancer	0.00317	0.0529	CrCbGaD
Dextroamphetamine—Urinary tract infection—Doxorubicin—liver cancer	0.00317	0.00516	CcSEcCtD
Dextroamphetamine—Sweating—Doxorubicin—liver cancer	0.00312	0.00509	CcSEcCtD
Dextroamphetamine—Selegiline—CYP2E1—liver cancer	0.00309	0.0514	CrCbGaD
Dextroamphetamine—Erythema multiforme—Epirubicin—liver cancer	0.00299	0.00487	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Doxorubicin—liver cancer	0.00276	0.00451	CcSEcCtD
Dextroamphetamine—Phenelzine—CYP2E1—liver cancer	0.00272	0.0453	CrCbGaD
Dextroamphetamine—Tension—Epirubicin—liver cancer	0.0027	0.0044	CcSEcCtD
Dextroamphetamine—Nervousness—Epirubicin—liver cancer	0.00267	0.00436	CcSEcCtD
Dextroamphetamine—Agitation—Epirubicin—liver cancer	0.00253	0.00412	CcSEcCtD
Dextroamphetamine—Tension—Doxorubicin—liver cancer	0.0025	0.00407	CcSEcCtD
Dextroamphetamine—Nervousness—Doxorubicin—liver cancer	0.00247	0.00403	CcSEcCtD
Dextroamphetamine—Palpitations—Epirubicin—liver cancer	0.00243	0.00396	CcSEcCtD
Dextroamphetamine—Convulsion—Epirubicin—liver cancer	0.00238	0.00389	CcSEcCtD
Dextroamphetamine—Hypertension—Epirubicin—liver cancer	0.00237	0.00387	CcSEcCtD
Dextroamphetamine—Chest pain—Epirubicin—liver cancer	0.00234	0.00382	CcSEcCtD
Dextroamphetamine—Agitation—Doxorubicin—liver cancer	0.00234	0.00381	CcSEcCtD
Dextroamphetamine—Anxiety—Epirubicin—liver cancer	0.00233	0.00381	CcSEcCtD
Dextroamphetamine—Dry mouth—Epirubicin—liver cancer	0.00229	0.00373	CcSEcCtD
Dextroamphetamine—Palpitations—Doxorubicin—liver cancer	0.00225	0.00367	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Epirubicin—liver cancer	0.00225	0.00366	CcSEcCtD
Dextroamphetamine—Infection—Epirubicin—liver cancer	0.00223	0.00364	CcSEcCtD
Dextroamphetamine—Convulsion—Doxorubicin—liver cancer	0.00221	0.0036	CcSEcCtD
Dextroamphetamine—Hypertension—Doxorubicin—liver cancer	0.0022	0.00358	CcSEcCtD
Dextroamphetamine—Tachycardia—Epirubicin—liver cancer	0.00219	0.00357	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Epirubicin—liver cancer	0.00217	0.00354	CcSEcCtD
Dextroamphetamine—Chest pain—Doxorubicin—liver cancer	0.00217	0.00353	CcSEcCtD
Dextroamphetamine—Anxiety—Doxorubicin—liver cancer	0.00216	0.00352	CcSEcCtD
Dextroamphetamine—Anorexia—Epirubicin—liver cancer	0.00214	0.00349	CcSEcCtD
Dextroamphetamine—Dry mouth—Doxorubicin—liver cancer	0.00212	0.00346	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Doxorubicin—liver cancer	0.00208	0.00339	CcSEcCtD
Dextroamphetamine—Infection—Doxorubicin—liver cancer	0.00206	0.00337	CcSEcCtD
Dextroamphetamine—Insomnia—Epirubicin—liver cancer	0.00203	0.00331	CcSEcCtD
Dextroamphetamine—Tachycardia—Doxorubicin—liver cancer	0.00203	0.00331	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Doxorubicin—liver cancer	0.00201	0.00327	CcSEcCtD
Dextroamphetamine—Dyspnoea—Epirubicin—liver cancer	0.002	0.00326	CcSEcCtD
Dextroamphetamine—Somnolence—Epirubicin—liver cancer	0.002	0.00325	CcSEcCtD
Dextroamphetamine—Anorexia—Doxorubicin—liver cancer	0.00198	0.00323	CcSEcCtD
Dextroamphetamine—Dyspepsia—Epirubicin—liver cancer	0.00198	0.00322	CcSEcCtD
Dextroamphetamine—Decreased appetite—Epirubicin—liver cancer	0.00195	0.00318	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Epirubicin—liver cancer	0.00194	0.00316	CcSEcCtD
Dextroamphetamine—Fatigue—Epirubicin—liver cancer	0.00194	0.00316	CcSEcCtD
Dextroamphetamine—Constipation—Epirubicin—liver cancer	0.00192	0.00313	CcSEcCtD
Dextroamphetamine—Insomnia—Doxorubicin—liver cancer	0.00188	0.00306	CcSEcCtD
Dextroamphetamine—Dyspnoea—Doxorubicin—liver cancer	0.00185	0.00302	CcSEcCtD
Dextroamphetamine—Somnolence—Doxorubicin—liver cancer	0.00185	0.00301	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Epirubicin—liver cancer	0.00184	0.00299	CcSEcCtD
Dextroamphetamine—Dyspepsia—Doxorubicin—liver cancer	0.00183	0.00298	CcSEcCtD
Dextroamphetamine—Decreased appetite—Doxorubicin—liver cancer	0.00181	0.00294	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00179	0.00292	CcSEcCtD
Dextroamphetamine—Fatigue—Doxorubicin—liver cancer	0.00179	0.00292	CcSEcCtD
Dextroamphetamine—Urticaria—Epirubicin—liver cancer	0.00178	0.00291	CcSEcCtD
Dextroamphetamine—Constipation—Doxorubicin—liver cancer	0.00178	0.0029	CcSEcCtD
Dextroamphetamine—Abdominal pain—Epirubicin—liver cancer	0.00177	0.00289	CcSEcCtD
Dextroamphetamine—Body temperature increased—Epirubicin—liver cancer	0.00177	0.00289	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Doxorubicin—liver cancer	0.0017	0.00277	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Epirubicin—liver cancer	0.00165	0.0027	CcSEcCtD
Dextroamphetamine—Urticaria—Doxorubicin—liver cancer	0.00165	0.00269	CcSEcCtD
Dextroamphetamine—Body temperature increased—Doxorubicin—liver cancer	0.00164	0.00268	CcSEcCtD
Dextroamphetamine—Abdominal pain—Doxorubicin—liver cancer	0.00164	0.00268	CcSEcCtD
Dextroamphetamine—Asthenia—Epirubicin—liver cancer	0.00161	0.00263	CcSEcCtD
Dextroamphetamine—Diarrhoea—Epirubicin—liver cancer	0.00154	0.0025	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Doxorubicin—liver cancer	0.00153	0.0025	CcSEcCtD
Dextroamphetamine—Nateglinide—ALB—liver cancer	0.00152	0.0253	CrCbGaD
Dextroamphetamine—Asthenia—Doxorubicin—liver cancer	0.00149	0.00243	CcSEcCtD
Dextroamphetamine—Dizziness—Epirubicin—liver cancer	0.00148	0.00242	CcSEcCtD
Dextroamphetamine—Vomiting—Epirubicin—liver cancer	0.00143	0.00233	CcSEcCtD
Dextroamphetamine—Diarrhoea—Doxorubicin—liver cancer	0.00142	0.00232	CcSEcCtD
Dextroamphetamine—Rash—Epirubicin—liver cancer	0.00142	0.00231	CcSEcCtD
Dextroamphetamine—Dermatitis—Epirubicin—liver cancer	0.00141	0.00231	CcSEcCtD
Dextroamphetamine—Headache—Epirubicin—liver cancer	0.00141	0.00229	CcSEcCtD
Dextroamphetamine—Dizziness—Doxorubicin—liver cancer	0.00137	0.00224	CcSEcCtD
Dextroamphetamine—Nausea—Epirubicin—liver cancer	0.00133	0.00217	CcSEcCtD
Dextroamphetamine—Vomiting—Doxorubicin—liver cancer	0.00132	0.00215	CcSEcCtD
Dextroamphetamine—Rash—Doxorubicin—liver cancer	0.00131	0.00214	CcSEcCtD
Dextroamphetamine—Dermatitis—Doxorubicin—liver cancer	0.00131	0.00213	CcSEcCtD
Dextroamphetamine—Headache—Doxorubicin—liver cancer	0.0013	0.00212	CcSEcCtD
Dextroamphetamine—Nausea—Doxorubicin—liver cancer	0.00123	0.00201	CcSEcCtD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—TRIO—liver cancer	0.000384	0.00117	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Biological oxidations—GSTM1—liver cancer	0.000382	0.00117	CbGpPWpGaD
Dextroamphetamine—SLC6A3—NRF2 pathway—TGFB1—liver cancer	0.000379	0.00116	CbGpPWpGaD
Dextroamphetamine—SLC6A3—SLC-mediated transmembrane transport—ALB—liver cancer	0.000378	0.00116	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metapathway biotransformation—GSTM1—liver cancer	0.000377	0.00115	CbGpPWpGaD
Dextroamphetamine—ADRA1A—AMPK Signaling—AKT1—liver cancer	0.000371	0.00114	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—CYCS—liver cancer	0.000368	0.00113	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CCR4—liver cancer	0.000368	0.00113	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Biological oxidations—CYP1A1—liver cancer	0.000362	0.00111	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000361	0.0011	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metapathway biotransformation—CYP1A1—liver cancer	0.000357	0.00109	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—IL2—liver cancer	0.000355	0.00109	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—TERT—liver cancer	0.000354	0.00108	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—TRIO—liver cancer	0.000348	0.00107	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—liver cancer	0.000346	0.00106	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	0.000342	0.00105	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—TRIO—liver cancer	0.000341	0.00104	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CCR4—liver cancer	0.000334	0.00102	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CCR4—liver cancer	0.000327	0.000999	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—KDR—liver cancer	0.000324	0.000991	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Neuronal System—RAF1—liver cancer	0.000323	0.000988	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transmembrane transport of small molecules—ALB—liver cancer	0.000322	0.000985	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—MAPK14—liver cancer	0.000322	0.000984	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—HMOX1—liver cancer	0.00032	0.000978	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—ESR1—liver cancer	0.000316	0.000966	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—F2—liver cancer	0.000312	0.000954	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—TRIO—liver cancer	0.000309	0.000947	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—liver cancer	0.000308	0.000942	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	0.000303	0.000928	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—PIK3CG—liver cancer	0.000298	0.000913	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—APC—liver cancer	0.000298	0.000913	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Neuronal System—HRAS—liver cancer	0.000298	0.000913	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CCR4—liver cancer	0.000297	0.000908	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—PPARA—liver cancer	0.000292	0.000892	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transmembrane transport of small molecules—RAF1—liver cancer	0.000291	0.000891	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—BRAF—liver cancer	0.00028	0.000858	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SHC3—liver cancer	0.000278	0.00085	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—UGDH—liver cancer	0.000271	0.000829	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—PIK3CD—liver cancer	0.000262	0.000802	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—F2—liver cancer	0.00026	0.000796	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—PIK3CA—liver cancer	0.00026	0.000795	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—SERPINE1—liver cancer	0.000259	0.000794	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—PPARA—liver cancer	0.000258	0.00079	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—KRAS—liver cancer	0.000257	0.000786	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—EPT1—liver cancer	0.000255	0.00078	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SHC3—liver cancer	0.000247	0.000755	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—TAT—liver cancer	0.000241	0.000739	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—PIK3CA—liver cancer	0.000236	0.000722	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—RAF1—liver cancer	0.000234	0.000716	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmission across Chemical Synapses—HRAS—liver cancer	0.000232	0.00071	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—F2—liver cancer	0.000231	0.000707	CbGpPWpGaD
Dextroamphetamine—ADRA1B—G alpha (q) signalling events—PIK3CA—liver cancer	0.000231	0.000705	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—PIK3CB—liver cancer	0.000229	0.000699	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—MTOR—liver cancer	0.000229	0.000699	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—liver cancer	0.000224	0.000687	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—HRAS—liver cancer	0.000218	0.000668	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—ALB—liver cancer	0.000217	0.000663	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FST—liver cancer	0.000216	0.00066	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CDKN1B—liver cancer	0.000214	0.000656	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—AKT1—liver cancer	0.000212	0.000649	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PRKCE—liver cancer	0.000212	0.000648	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CASP3—liver cancer	0.00021	0.000643	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—IL2—liver cancer	0.00021	0.000642	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—IL6—liver cancer	0.000209	0.000639	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—liver cancer	0.000206	0.000631	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TRIO—liver cancer	0.000206	0.00063	CbGpPWpGaD
Dextroamphetamine—ADRA1A—G alpha (q) signalling events—PIK3CA—liver cancer	0.000205	0.000627	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CCND1—liver cancer	0.000205	0.000626	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—JUN—liver cancer	0.000204	0.000625	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CTNNB1—liver cancer	0.000203	0.00062	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—liver cancer	0.000199	0.00061	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—MMP9—liver cancer	0.000199	0.000608	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CDKN1A—liver cancer	0.000198	0.000606	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCR4—liver cancer	0.000197	0.000604	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—RAF1—liver cancer	0.000196	0.0006	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—MAPK8—liver cancer	0.000193	0.000591	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—AKT1—liver cancer	0.000193	0.00059	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PRKCE—liver cancer	0.000192	0.000588	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—ALB—liver cancer	0.000192	0.000587	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FST—liver cancer	0.000192	0.000586	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—liver cancer	0.000191	0.000584	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PRKCE—liver cancer	0.000188	0.000575	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CSF2—liver cancer	0.000187	0.000573	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—liver cancer	0.000183	0.00056	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TRIO—liver cancer	0.000183	0.000559	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—liver cancer	0.000183	0.000559	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—VEGFA—liver cancer	0.000178	0.000546	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Neuronal System—HRAS—liver cancer	0.000178	0.000544	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—STAT3—liver cancer	0.000177	0.000541	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCR4—liver cancer	0.000175	0.000536	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—RAF1—liver cancer	0.000174	0.000531	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PRKCE—liver cancer	0.000171	0.000523	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CSF2—liver cancer	0.00017	0.00052	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—liver cancer	0.000169	0.000518	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CSF2—liver cancer	0.000166	0.000509	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GLUL—liver cancer	0.000164	0.000502	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CPT1B—liver cancer	0.000164	0.000502	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—MYC—liver cancer	0.000164	0.000502	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—TGFB1—liver cancer	0.000164	0.000501	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—liver cancer	0.000162	0.000496	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—NR1H4—liver cancer	0.000158	0.000484	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ADAM17—liver cancer	0.000156	0.000477	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTA3—liver cancer	0.000156	0.000476	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—KRAS—liver cancer	0.000152	0.000464	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CSF2—liver cancer	0.000151	0.000462	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—F2—liver cancer	0.000147	0.00045	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PSMA4—liver cancer	0.000147	0.000449	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PSMD10—liver cancer	0.000147	0.000449	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTA4—liver cancer	0.000142	0.000436	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PIK3CG—liver cancer	0.000141	0.00043	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—PIK3CA—liver cancer	0.000139	0.000426	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTA2—liver cancer	0.000139	0.000424	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ADAM17—liver cancer	0.000138	0.000424	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—TP53—liver cancer	0.000135	0.000412	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTA1—liver cancer	0.000134	0.00041	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—F2—liver cancer	0.000133	0.000408	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—NAT2—liver cancer	0.000132	0.000405	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—F2—liver cancer	0.000131	0.0004	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PSMA4—liver cancer	0.00013	0.000398	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PSMD10—liver cancer	0.00013	0.000398	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—HRAS—liver cancer	0.000129	0.000394	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PIK3CG—liver cancer	0.000128	0.000391	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ALDOB—liver cancer	0.000127	0.000388	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PIK3CG—liver cancer	0.000125	0.000382	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PIK3CD—liver cancer	0.000124	0.000378	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—IL6—liver cancer	0.000123	0.000378	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CRABP1—liver cancer	0.000121	0.00037	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—F2—liver cancer	0.000119	0.000363	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—AKT1—liver cancer	0.000114	0.000348	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PRKCE—liver cancer	0.000114	0.000348	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3CG—liver cancer	0.000113	0.000347	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PIK3CD—liver cancer	0.000112	0.000344	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PIK3CD—liver cancer	0.00011	0.000336	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PIK3CB—liver cancer	0.000108	0.00033	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IGF2—liver cancer	0.000108	0.000329	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—HPGDS—liver cancer	0.000106	0.000324	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PRKCE—liver cancer	0.000101	0.000309	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CSF2—liver cancer	0.0001	0.000307	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—RAF1—liver cancer	0.0001	0.000307	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3CD—liver cancer	9.97e-05	0.000305	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—H2AFX—liver cancer	9.9e-05	0.000303	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—IL2—liver cancer	9.9e-05	0.000303	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PIK3CB—liver cancer	9.79e-05	0.0003	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PIK3CB—liver cancer	9.57e-05	0.000293	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IGF2—liver cancer	9.56e-05	0.000292	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PSMD10—liver cancer	9.43e-05	0.000289	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PSMA4—liver cancer	9.43e-05	0.000289	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GOT2—liver cancer	9.17e-05	0.000281	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—IL2—liver cancer	8.99e-05	0.000275	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TERT—liver cancer	8.96e-05	0.000274	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CSF2—liver cancer	8.92e-05	0.000273	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—RAF1—liver cancer	8.9e-05	0.000272	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—H2AFX—liver cancer	8.8e-05	0.000269	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—IL2—liver cancer	8.79e-05	0.000269	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3CB—liver cancer	8.69e-05	0.000266	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP2E1—liver cancer	8.62e-05	0.000264	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—KDR—liver cancer	8.19e-05	0.000251	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MAPK14—liver cancer	8.14e-05	0.000249	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYCS—liver cancer	8.07e-05	0.000247	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—IL2—liver cancer	7.98e-05	0.000244	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ESR1—liver cancer	7.98e-05	0.000244	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TERT—liver cancer	7.95e-05	0.000243	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GOT1—liver cancer	7.92e-05	0.000242	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GGT1—liver cancer	7.92e-05	0.000242	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—F2—liver cancer	7.88e-05	0.000241	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—APC—liver cancer	7.54e-05	0.000231	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3CG—liver cancer	7.54e-05	0.000231	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—KDR—liver cancer	7.28e-05	0.000223	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MAPK14—liver cancer	7.23e-05	0.000221	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTP1—liver cancer	7.11e-05	0.000218	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—BRAF—liver cancer	7.09e-05	0.000217	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ESR1—liver cancer	7.09e-05	0.000217	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—HMOX1—liver cancer	7.01e-05	0.000215	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—F2—liver cancer	7e-05	0.000214	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3CG—liver cancer	6.7e-05	0.000205	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—APC—liver cancer	6.7e-05	0.000205	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3CD—liver cancer	6.63e-05	0.000203	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PIK3CA—liver cancer	6.57e-05	0.000201	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SERPINE1—liver cancer	6.56e-05	0.000201	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTM1—liver cancer	6.54e-05	0.0002	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—KRAS—liver cancer	6.49e-05	0.000199	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—BRAF—liver cancer	6.3e-05	0.000193	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP1A1—liver cancer	6.2e-05	0.00019	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PIK3CA—liver cancer	5.97e-05	0.000183	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—RAF1—liver cancer	5.92e-05	0.000181	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3CD—liver cancer	5.89e-05	0.00018	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PIK3CA—liver cancer	5.84e-05	0.000179	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SERPINE1—liver cancer	5.83e-05	0.000178	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3CB—liver cancer	5.78e-05	0.000177	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MTOR—liver cancer	5.78e-05	0.000177	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—MTHFR—liver cancer	5.78e-05	0.000177	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—KRAS—liver cancer	5.77e-05	0.000177	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PPARA—liver cancer	5.67e-05	0.000173	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—HRAS—liver cancer	5.52e-05	0.000169	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CDKN1B—liver cancer	5.43e-05	0.000166	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—AKT1—liver cancer	5.37e-05	0.000164	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CASP3—liver cancer	5.32e-05	0.000163	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IL2—liver cancer	5.31e-05	0.000162	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3CA—liver cancer	5.3e-05	0.000162	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—IL6—liver cancer	5.28e-05	0.000162	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—RAF1—liver cancer	5.26e-05	0.000161	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCND1—liver cancer	5.18e-05	0.000158	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—JUN—liver cancer	5.16e-05	0.000158	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MTOR—liver cancer	5.14e-05	0.000157	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3CB—liver cancer	5.14e-05	0.000157	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CTNNB1—liver cancer	5.13e-05	0.000157	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MMP9—liver cancer	5.03e-05	0.000154	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CDKN1A—liver cancer	5.01e-05	0.000153	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—HRAS—liver cancer	4.9e-05	0.00015	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MAPK8—liver cancer	4.89e-05	0.00015	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—AKT1—liver cancer	4.87e-05	0.000149	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3CG—liver cancer	4.85e-05	0.000149	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CDKN1B—liver cancer	4.82e-05	0.000147	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—AKT1—liver cancer	4.77e-05	0.000146	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CASP3—liver cancer	4.72e-05	0.000145	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IL2—liver cancer	4.72e-05	0.000144	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—IL6—liver cancer	4.69e-05	0.000144	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PPARG—liver cancer	4.68e-05	0.000143	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCND1—liver cancer	4.6e-05	0.000141	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—JUN—liver cancer	4.59e-05	0.00014	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CTNNB1—liver cancer	4.55e-05	0.000139	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—VEGFA—liver cancer	4.51e-05	0.000138	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—STAT3—liver cancer	4.47e-05	0.000137	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MMP9—liver cancer	4.46e-05	0.000137	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CDKN1A—liver cancer	4.45e-05	0.000136	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MAPK8—liver cancer	4.34e-05	0.000133	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—AKT1—liver cancer	4.33e-05	0.000132	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3CD—liver cancer	4.27e-05	0.000131	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ALB—liver cancer	4.21e-05	0.000129	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MYC—liver cancer	4.15e-05	0.000127	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TGFB1—liver cancer	4.14e-05	0.000127	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—VEGFA—liver cancer	4.01e-05	0.000123	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—STAT3—liver cancer	3.97e-05	0.000121	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—KRAS—liver cancer	3.84e-05	0.000117	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3CB—liver cancer	3.72e-05	0.000114	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MYC—liver cancer	3.69e-05	0.000113	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TGFB1—liver cancer	3.68e-05	0.000113	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3CA—liver cancer	3.52e-05	0.000108	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TP53—liver cancer	3.41e-05	0.000104	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—KRAS—liver cancer	3.41e-05	0.000104	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HRAS—liver cancer	3.26e-05	9.98e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3CA—liver cancer	3.13e-05	9.58e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IL6—liver cancer	3.12e-05	9.55e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TP53—liver cancer	3.03e-05	9.27e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HRAS—liver cancer	2.9e-05	8.86e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AKT1—liver cancer	2.88e-05	8.81e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IL6—liver cancer	2.77e-05	8.48e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AKT1—liver cancer	2.56e-05	7.83e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3CA—liver cancer	2.27e-05	6.94e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—AKT1—liver cancer	1.85e-05	5.67e-05	CbGpPWpGaD
